CINECA IRIS Institutional Research Information System

CAVIGLIA, Gian Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.664
EU - Europa 7.968
AS - Asia 4.740
SA - Sud America 420
AF - Africa 264
OC - Oceania 142
Continente sconosciuto - Info sul continente non disponibili 18
Totale 25.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.199
CN - Cina 2.450
IT - Italia 1.886
SE - Svezia 955
IE - Irlanda 886
DE - Germania 822
FR - Francia 567
JP - Giappone 437
GB - Regno Unito 414
UA - Ucraina 350
VN - Vietnam 334
CA - Canada 326
IN - India 315
TR - Turchia 268
ES - Italia 264
KR - Corea 259
FI - Finlandia 256
BR - Brasile 237
PL - Polonia 225
RU - Federazione Russa 194
AT - Austria 192
BE - Belgio 192
DK - Danimarca 166
NL - Olanda 161
TW - Taiwan 138
AU - Australia 114
MX - Messico 114
HK - Hong Kong 87
EG - Egitto 86
ID - Indonesia 80
CH - Svizzera 72
RO - Romania 70
GR - Grecia 69
IR - Iran 65
SG - Singapore 55
CO - Colombia 51
PT - Portogallo 43
IL - Israele 40
CL - Cile 36
PE - Perù 34
PK - Pakistan 33
TH - Thailandia 33
PH - Filippine 30
AR - Argentina 29
HU - Ungheria 29
HR - Croazia 28
NZ - Nuova Zelanda 27
CZ - Repubblica Ceca 25
MY - Malesia 25
KE - Kenya 24
UZ - Uzbekistan 23
ZA - Sudafrica 22
EC - Ecuador 20
NG - Nigeria 20
SI - Slovenia 19
NO - Norvegia 18
BG - Bulgaria 17
EU - Europa 17
TN - Tunisia 17
SA - Arabia Saudita 16
CM - Camerun 15
DZ - Algeria 15
IQ - Iraq 12
VE - Venezuela 12
RS - Serbia 10
SD - Sudan 9
ZM - Zambia 9
BA - Bosnia-Erzegovina 8
ET - Etiopia 7
GM - Gambi 7
MA - Marocco 7
BF - Burkina Faso 6
BY - Bielorussia 6
CU - Cuba 6
MN - Mongolia 6
SK - Slovacchia (Repubblica Slovacca) 6
AF - Afghanistan, Repubblica islamica di 5
JO - Giordania 5
MK - Macedonia 5
PA - Panama 5
CR - Costa Rica 4
MZ - Mozambico 4
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
HN - Honduras 3
SN - Senegal 3
TZ - Tanzania 3
AL - Albania 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CD - Congo 2
GH - Ghana 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MU - Mauritius 2
NP - Nepal 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
Totale 25.192
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.477
Chandler 1.460
Beijing 996
Dublin 873
Fairfield 712
Redwood City 518
Torino 457
Houston 426
Wilmington 384
Woodbridge 375
Nyköping 322
Jacksonville 310
Villeurbanne 295
Ashburn 279
Dearborn 272
Medford 262
Princeton 238
Seattle 225
Cambridge 218
Pisa 197
Shanghai 183
Vienna 179
Ottawa 178
Dong Ket 173
Guangzhou 150
Brussels 146
Fremont 142
Warsaw 138
Hangzhou 99
Boston 96
Tokyo 96
Rome 94
Turin 87
Nanjing 86
Milan 83
Taipei 82
Wuhan 78
San Diego 73
Seoul 73
Boardman 66
Chengdu 63
Istanbul 55
Toronto 53
Barcelona 48
London 46
Zhengzhou 42
Washington 41
Hanoi 40
Hebei 39
Madrid 39
Hyderabad 38
Jakarta 38
Bengaluru 37
Duncan 36
Jinan 36
San Mateo 35
Norwalk 33
Paris 33
Hefei 32
Upper Marlboro 32
Ankara 30
Central District 30
Chongqing 30
Kunming 30
Munich 30
Amsterdam 26
New York 26
São Paulo 26
Changchun 25
Fuzhou 25
Hanover 25
Naples 25
Santiago 23
Cairo 22
Falls Church 22
Singapore 22
Tianjin 22
Xian 22
Bologna 21
Phoenix 21
Silver Spring 21
Berlin 20
Bucharest 20
Changsha 20
Lima 20
Moscow 20
Mountain View 20
Ho Chi Minh City 19
Rochester 19
Chicago 17
Delhi 17
Melbourne 17
Saint Petersburg 16
San Francisco 16
Athens 15
Linköping 15
Los Angeles 15
Polska 15
Rotterdam 15
Indore 14
Totale 14.268
Salva come PNG Salva come JPEG
Nome #
Serum zonulin in patients with inflammatory bowel disease: a pilot study 1.452
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 852
Risk of drug interactions and prescription appropriateness in elderly patients 841
Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response 569
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. 481
Biochemical markers of bone metabolism during early orthodontic tooth movement with aligners 450
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study 441
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis 432
Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: Correlation with the ARCHITECT quantitative assays. 369
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin for hepatocellular carcinoma detection 327
Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α 320
Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data 316
Outcome of chronic delta hepatitis in Italy: a long-term cohort study. 305
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets 293
Chronic hepatitis B therapy: available drugs and treatment guidelines. 289
Management of Helicobacter pylori in Piedmont, Italy 270
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II 263
Fecal calprotectin: beyond intestinal organic diseases 257
Endocrine manifestations of chronic HCV infection 256
Chronic HCV infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, MGUS and B-cell non-Hodgkin lymphoma. 247
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 244
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study 221
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis 207
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease 204
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. 203
Physiopathology of intestinal barrier and the role of zonulin 199
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner. 183
AISF position paper on liver disease and pregnancy. 182
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop 180
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy 173
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message 168
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers 164
The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia 161
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 159
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease 158
Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index 156
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 149
F-8 Importance of HLA-B in the sustained virological response in patients with chronic hepatitis C treated with peg-IFN and ribavirin 145
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")? 145
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study 140
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 135
Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease. 134
Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test 129
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis 125
Liver fibrosis: the 2017 state of art 124
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 124
Re: El-Garem et al.: Seminal Helicobacter pylori Treatment Improves Sperm Motility in Infertile Asthenozoospermic Men (Urology 2014;84:1347-1350). 122
Treatment of hepatitis D, an unmet medical need 122
LIPIDOMICS REVEALS THAT LOW PLASMA UNSATURATED TO SATURATED FAT RATIOS ARE BIOMARKERS OF NAFLD AND LIVER DAMAGE 121
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation 121
Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Viral Response in Patients with Genotype 1 Chronic Hepatitis C 120
Alteration in glucose metabolism after an oral glucose load and relationship with liver damage in patients with NAFLD. 119
Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR 118
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test 118
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease 118
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease? 116
Hepatitis B Core-Related Antigen: A Serum Biomarker for Intrahepatic Covalently-Closed-Circular DNA 114
Validation of surrogate indexes of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic Fatty Liver Disease 113
Basic and clinical aspects of resistin 113
Metabolic handling of an oral fat load in NAFLD patients. 113
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients 113
Impact of fat versus glucose load on oxidative stress in non-alcoholic fatty liver disease. 112
Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma 112
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease 112
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 111
CLINIC EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HBV CHRONIC INFECTION 110
Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction 110
Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease. 106
Serum cytokeratin-19 fragments (CYFRA 21-1) for the prediction of overall survival in patients with hepatocellular carcinoma 104
Oxidative stress-inducible factors promote liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease. 101
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 101
Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease. 101
IL28Bpolymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients 100
The combination of Index of NASH score and liver stiffness improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with NonAlcoholic Fatty Liver Disease. 100
Matabolomic analysis identifies new biomarkers of liver damage in NAFLD 99
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 99
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 99
Quantitative and qualitative analysis of plasma free fatty acids and their impact on liver damage in NAFLD patients. 98
ETIOLOGY OF CHRONIC LIVER DISEASES IN THE NORTHWEST OF ITALY, 1998 THROUGH 2014 98
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology 97
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 97
CLINICAL EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HBV INFECTION 95
Prevalence of patients with non-alcoholic fatty liver disease: from primary care to tertiary centers. The Turin experience 95
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 95
Serum levels of protein induced by vitamin K absence or antagonist-II (PIVKA-II) and alpha-fetoprotein (AFP) at baseline predict overall survival in patients with hepatocellular carcinoma (HCC) 94
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma 94
Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy 93
PNPLA3 gene variants and insulin resistance in patients with genotype-1 chronic hepatitis C 92
Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis 92
Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in chronic hepatitis D 91
Helicobacter pylori, gastric cancer and gastric cancer stem cells 91
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study 91
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology 90
Faecal miRNA profiles associated with age, sex, BMI, and lifestyle habits in healthy individuals 90
Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis 89
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA 89
Alteration in lipid metabolism after an oral fat load in patients with NAFLD. 88
Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease 88
Comment on "Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study" 88
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis 88
Totale 18.903
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.573
article - articoli 0
book - libri 0
conference - conferenze 15.012
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.731 0 0 134 109 111 137 98 232 113 249 360 188
2019/20203.639 178 145 124 341 233 446 310 314 414 519 297 318
2020/20214.288 301 353 310 294 381 340 297 249 380 367 376 640
2021/20225.748 292 304 344 449 406 340 670 549 477 421 868 628
2022/20235.687 497 443 242 497 462 1.103 559 393 553 261 396 281
2023/20241.183 436 524 223 0 0 0 0 0 0 0 0 0
Totale 26.300